RCM
GWPH

Riverloft Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Riverloft Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,000
Closed -$271K – 67
2014
Q4 		$271K Buy
+4,000
New +$292K 0.13% 56

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Riverloft Capital Management's GWPH Position: Q1 2015 in Review

Riverloft Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2015, closing a stake of 4,000 shares — an estimated $271K sold.

Riverloft Capital Management first reported a position in GWPH in Q4 2014 and held it in 1 quarter. The position peaked at $271K in Q4 2014. 92 funds tracked by Wall St. Rank hold GWPH as of Q1 2015.

  • Riverloft Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2015 after selling out during the quarter.
  • Riverloft Capital Management sold 4,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2015, an estimated $271K.
  • Riverloft Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 1 quarter.
  • Riverloft Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $271K in Q4 2014.
  • 92 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2015.

Based on Riverloft Capital Management's 13F filing for Q1 2015, filed 13 May 2015.